ALK2 (ACVR1), GST-tag Recombinant
Catalog #
40019
$390
*
●
●
Purchase
Description
Recombinant human ALK2 a.a. 147-509(end), Genbank Accession No. NM_001105.5, with an N-terminal GST-tag, expressed in Sf9 cells using a baculovirus expression system. MW = 67 kDa.
●
Synonyms
ACVRLK2, FOP, SKR1, TSRI, ALK
●
Product Data Gallery
Product Info
Storage and Usage
Citations
Species
Human
Host Species/Expression System
Sf9 insect cells
Purity
≥90%
Format
Aqueous buffer solution
Formulation
40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 20 % Glycerol and 3 mM DTT
MW
67 kDa
Amino Acids
147-509 (end)
Specific Activity
40 pmol/min/µg
Genbank #
NM_001105.5
UniProt #
Q04771
Background
ALK 2 is a receptor serine/threonine kinase that is member of the ALK family and is upstream of signaling pathway involving the SMAD proteins especially SMAD1/5/8. Knockdown of ALK2, but not TGFβRI (ALK5), abrogates endoglin-mediated decrease in cell motility of prostate cancer cells and constitutively active ALK2 is sufficient to restore a low-motility phenotype in endoglin deficient cells (1). Therefore, endoglin decreases prostate cancer cell motility through activation of the ALK2-Smad1 pathway. ALK2 is the key gene involved in Fibrodysplasia ossificans progressiva (FOP), a rare autosomal dominant congenital disorder characterized by progressive heterotopic bone formation in muscle tissues (2).
References
1. Craft, C.S. et al . Oncogene. 2007 Nov 8;26(51):7240-50.
2. Shore, E. M. et al . Nature Genet. 38: 525-527, 2006.
2. Shore, E. M. et al . Nature Genet. 38: 525-527, 2006.